A Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Healthy Children, Adults, and Elderly
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1509648
Full Text
Open PDFAbstract
Available in full text
Date
September 21, 2018
Authors
Publisher
Informa UK Limited